NCT00477529 2019-11-22ABI-008 Trial in Patients With Hormone-refractory Prostate CancerCelgenePhase 1/2 Completed102 enrolled
NCT00286806 2010-08-24A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate CancerAscenta TherapeuticsPhase 1/2 Completed27 enrolled